La Jolla Pharmaceutical’s stock rockets in active trade after positive trial results – MarketWatch


TheStreet.com
La Jolla Pharmaceutical’s stock rockets in active trade after positive trial results
MarketWatch
Shares of La Jolla Pharmaceutical Co. LJPC, +80.71% rocketed 51% in active premarket trade Monday, after the drug maker announced positive results from a phase 3 trial of its hypotension treatment. Volume topped 126,000 shares about two hours before …
La Jolla Pharmaceutical (LJPC) Reports Statistically Significant LJPC-501 Phase 3 ResultsStreetInsider.com
La Jolla Pharmaceutical Stock Spikes on Positive Trial ResultsTheStreet.com
La Jolla Pharmaceutical (LJPC) Has Surged To A New High On Phase 3 ResultsNasdaq
Schaeffers Research (blog) -Investorplace.com -CNA Finance (press release)
all 49 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd